Revvity Board Declares Quarterly Dividend
Key Highlights
- ➤$0.07 quarterly dividend declared, payable February 12, 2027
- ➤January 22, 2027 record date set for dividend eligibility
- ➤2025 revenue reached $2.9 billion with approximately 11,000 employees
The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 12, 2027 to all shareholders of record at the close of business on January 22, 2027.
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
Get started
Create a free account to read the full story.